Proportions of myxoma cells, CD8 + T cells, CD8- T cells, CD206+ macrophages, and CD206- macrophages showed significant variability across patients (Fig. 2c, Supplementary Fig. 4a, Data S4). This evidence concerns the gene MRC1 and myxoma.